{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:11025495",
      "entity_text" : "cholesterol",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "be:HDL",
      "entity_text" : "HDL",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In conclusion, our in vivo study using rabbits demonstrated that treatment with rosiglitazone increased serum HDL-C levels, and improved the HDL induced cholesterol efflux in hepatic cells and macrophages by upregulating ABCA1 and SR-B1 mRNA and protein expression in an atherosclerotic rabbit model.",
  "reading_complete" : "2020-08-03T16:55:29Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T16:54:20Z",
  "trigger" : "induced",
  "evidence" : [ "HDL-induced cholesterol" ],
  "pmc_id" : "4314417",
  "score" : 0
}